Nephros Inc (NEPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2005 | 12-2004 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 747 | 3,710 |
| Marketable Securities | 4,500 | 5,990 |
| Receivables | 244 | 170 |
| Inventories | 815 | 650 |
| Other current assets | 0 | 490 |
| TOTAL | $6,664 | $11,010 |
| Non-Current Assets | ||
| PPE Net | 1,143 | 1,190 |
| Other Non-Current Assets | 18 | 3 |
| TOTAL | $1,161 | $1,193 |
| Total Assets | $7,825 | $12,200 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 766 | 630 |
| Accrued Expenses | 769 | 1,860 |
| Other current liabilities | N/A | 60 |
| TOTAL | $1,831 | $2,550 |
| Non-Current Liabilities | ||
| Long Term Debt | 614 | 0 |
| TOTAL | $614 | $N/A |
| Total Liabilities | $2,445 | $2,550 |
| Shareholders' Equity | ||
| Common Shares | 12 | 10 |
| Retained earnings | -47,243 | -41,770 |
| Other shareholders' equity | -2,239 | -2,330 |
| TOTAL | $5,380 | $9,650 |
| Total Liabilities And Equity | $7,825 | $12,200 |